Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Merge eMed to Showcase Innovative Software Solutions at Society of Computer Applications in Radiology (SCAR)

   Merge Healthcare logo. (PRNewsFoto)

MILWAUKEE, WI USA
 Merge eMed Showcases Powerful 64-Bit Processing in FUSION Matrix PACS and
RIS/PACS Solutions That Enables Users to Simultaneously Load, View, Compare
                and Manipulate More Images Than Ever Before

    MILWAUKEE, April 26 /PRNewswire-FirstCall/ -- Merge Healthcare (Nasdaq:
MRGE; TSX: MRG), a leader in healthcare software and services, today
announced that it will showcase its FUSION Matrix PACS 64-bit processing
technology at SCAR, April 27 - 29, in Austin, TX.
    (Logo: http://www.newscom.com/cgi-bin/prnh/20030430/MRGELOGO )
    Merge eMed continues its innovation with the first PACS workstation
ported to a 64-bit environment. The 64-Bit Edition of FUSION Matrix PACS
enables radiologists to easily load and manipulate studies regardless of
size. With this innovative solution, comparison is possible with as many
priors as needed. Performance testing has supported loading more than
10,000 studies simultaneously without any erosion of workstation
performance. The power of 64-bit far surpasses existing limits on memory
usage. When combined with the FUSION RIS, users gain full clinical and
business workflow that can substantially accelerate productivity.
    "Merge eMed has led the way with RIS/PACS/Clinical Applications, and
this 64-Bit Edition leverages our depth of understanding of imaging
workflow," says Robert White, Merge eMed President. "As modalities become
more sophisticated, our customers require efficient and effective solutions
to accommodate their output in ways that accelerate productivity. Our
solution has revolutionized the way large studies such as thin-slice CT and
breast MR studies can be read and compared with priors. It's innovations
like these in our RIS/PACS/Clinical Applications portfolio that
differentiate us from our competitors."
    FUSION Matrix PACS is part of the Merge eMed RIS, PACS and Clinical
Applications portfolio. Demonstrations of the entire product portfolio will
be available to SCAR attendees at booth 745, including mammography and PET
CT.
    Merge Healthcare is a market leader in the development and delivery of
medical imaging and information management software and services. Our
innovative software solutions use leading-edge imaging software
technologies that accelerate market delivery for our OEM customers, while
our end-user solutions improve our customers' productivity and enhance the
quality of patient care they provide. For additional information, visit our
website at http://www.merge.com .
    Merge eMed, a Merge Healthcare company, is focused on accelerating
productivity for radiology departments and specialty practices, imaging
centers and hospitals. By combining sophisticated RIS, PACS, advanced
visualization and clinical imaging applications, Merge eMed delivers
integrated end-to-end software solutions and professional services that are
transforming the way our customers interact with referring physicians,
manage their workflow, position their businesses in their markets and
deliver imaging and information services to their customers. For additional
information, visit our website at http://www.merge-emed.com .
    Except for the historical information herein, the matters discussed in
this news release include forward-looking statements that may involve a
number of risks and uncertainties. When used in this press release, the
words: guidance, believes, intends, anticipates, expects, and similar
expressions are intended to identify forward-looking statements. Actual
results could differ materially from those projected in the forward-looking
statements based on a number of factors, including, but not limited to,
risks in product and technology development, market acceptance of new
products and continuing product demand, the impact of competitive products
and pricing, ability to integrate acquisitions, unexpected outcomes to any
pending or future litigation, changing economic conditions, credit and
payment risks associated with end-user sales, dependence on major
customers, dependence on key personnel, and other risk factors detailed in
filings with the Securities and Exchange Commission. The Company undertakes
no obligation to publicly release the result of any revisions to these
forward-looking statements that may be made to reflect any future events or
circumstances.


SOURCE Merge Healthcare




Back to Topback to top

Related links:
  • http://www.merge-emed.com
  • http://www.merge.com
    Photo Notes:
    NewsCom: http://www.newscom.com/cgi-bin/prnh/20030430/MRGELOGO
    AP Archive: http://photoarchive.ap.org
    PRN Photo Desk, photodesk@prnewswire.com
    CONTACT:
    Beth Frost-Johnson, Sr. VP of Marketing,
    +1-414-977-4254, bfrost@merge.com , or Richard Linden, President
    and CEO, +1-414-977-4000, rlinden@merge.com , both of Merge
    Healthcare